HSV and varicella zoster virus (VZV ... Cytological and morphological examination, specific antibody detection methods and virus isolation all have their own limitations in clinical practice.

New research suggests that the shingles vaccine could lower your risk of developing dementia. Here's what the study says and ...

Researchers exploit a natural experiment in Wales to isolate the vaccine’s protective effect against dementia.

Therefore, the authors conclude that Oka vaccine-strain varicella-zoster virus (VZV) reactivates as serum antibody decreases post-vaccination. However, the 13% incidence figure is based on very ...

G etting vaccinated for the viral illness shingles, which causes a painful rash, could potentially be the next best tool in ...

the Shingrix vaccine uses a protein from the varicella zoster virus to stimulate the body to produce antibodies against the disease. Usually, the second dose is given two to six months after the ...

Several previous studies have suggested that shingles vaccinations might reduce dementia risk, but most could not exclude the ...

We administered live attenuated varicella vaccine to 187 healthy adults seronegative to varicella-zoster ... vaccine virus to others. Seroconversions to VZV, measured by fluorescent antibody ...

Study in older adults found that individuals who received the shingles vaccine were 20% less likely to develop dementia than those who were unvaccinated.

If the clinical sample contains viable virus, cytopathic effects due to the ... fluorescently labeled anti-HSV-1/2 and VZV monoclonal antibodies. Cell culture has greater sensitivity for the ...